A clinical trial of a nasal-spray version of the Covid-19 vaccine jointly developed by the University of Oxford researchers and AstraZeneca, in human beings, has failed and did not offer the desired protection.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,